Today's Top Stories


Hot Topics


Comment & Analysis »

GBI Research

Personalised medicine: Delving into our DNA

At present, a patient’s treatment for a disorder is not specifically matched to them, and is the same for everyone else with that...

Personalised medicine: Delving into our DNA
Naga Divya Tirumalaraju

July’s top stories: NCI and COG’s paediatric precision cancer trial, AstraZeneca’s NSCLC trial results

July’s top stories: NCI and COG’s paediatric precision cancer trial, AstraZeneca’s NSCLC trial results
GlobalData Healthcare

Chronic traumatic encephalopathy - a potential orphan indication for Alzheimer's drugs

Chronic traumatic encephalopathy - a potential orphan indication for Alzheimer's drugs
GlobalData Healthcare

Precision medicine makes way for the human microbiome

Precision medicine makes way for the human microbiome
GlobalData Healthcare

Slow progress in pancreatic cancer treatment

Slow progress in pancreatic cancer treatment

Company Releases »

Benefits of Trehalose

Pfanstiehl
Benefits of Trehalose

Stability Analysis of Proteins for the Biopharmaceutical Industry

Malvern Instruments
Stability Analysis of Proteins for the Biopharmaceutical Industry

Softigel by Procaps Brochure

Softigel Softigel by Procaps Brochure

The ImmunoPrecise Rapid Prime System Reduces the Immunization Stage of Hybridoma Production to 18 Days

ImmunoPrecise Antibodies
The ImmunoPrecise Rapid Prime System Reduces the Immunization Stage of Hybridoma Production to 18 Days

Orthotopic and metastasis models for preclinical efficacy testing of novel cancer drugs

Pharmatest Services Orthotopic and metastasis models for preclinical efficacy testing of novel cancer drugs

Drugdevelopment Insights »

Drugdevelopment Industry Reports »

PMDA approvals pivot to oncology

PMDA approvals pivot to oncology

Acute Myeloid Leukemia: noticeable differences in subtypes by age

Acute Myeloid Leukemia: noticeable differences in subtypes by age

A success story: the human papillomavirus vaccine

A success story: the human papillomavirus vaccine

Bispecific antibodies and CAR-T cells: A comparison of historical trial numbers and patient recruitment

Bispecific antibodies and CAR-T cells: A comparison of historical trial numbers and patient recruitment








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115